|
|
|
|
LEADER |
01000naa a22002652 4500 |
001 |
NLM251439712 |
003 |
DE-627 |
005 |
20231224162026.0 |
007 |
cr uuu---uuuuu |
008 |
231224s2015 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1016/j.clim.2015.06.013
|2 doi
|
028 |
5 |
2 |
|a pubmed24n0838.xml
|
035 |
|
|
|a (DE-627)NLM251439712
|
035 |
|
|
|a (NLM)26232673
|
035 |
|
|
|a (PII)S1521-6616(15)30004-8
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Vlkova, Marcela
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Regulatory B cells in CVID patients fail to suppress multifunctional IFN-γ+ TNF-α+ CD4+ T cells differentiation
|
264 |
|
1 |
|c 2015
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 15.12.2015
|
500 |
|
|
|a Date Revised 09.01.2021
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a Copyright © 2015 Elsevier Inc. All rights reserved.
|
520 |
|
|
|a Common variable immunodeficiency (CVID) refers to primary hypogammaglobulinemia with unknown pathogenesis. Although there is evidence for intrinsic B cell defects in some CVID patient groups, various abnormalities in cytokine production by T cells in CVID patients are frequently observed. Here, we demonstrate a relationship in the production of pro-inflammatory Th1 cytokines and regulatory B cells producing IL-10 between CVID patients and healthy controls. We describe CD19(+)CD24(hi)CD38(hi)IL-10(+) regulatory B cells generated after T cell stimulation of human peripheral blood lymphocytes ex vivo are able to suppress IFN-γ(+)TNF-α(+) producing CD4(+) T cells. This process is impaired in CVID patients, who present with both low numbers of CD19(+)CD24(hi)CD38(hi)IL-10(+) B cells and increased numbers of IFN-γ(+)TNF-α(+)CD4(+) T cells. Disruption of the regulatory B cell response to T cell stimulation explains the excessive T cell activation regarded as an immunoregulatory abnormality that is a frequent finding in CVID patients
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
650 |
|
4 |
|a B cell
|
650 |
|
4 |
|a Common variable immunodeficiency (CVID)
|
650 |
|
4 |
|a Cytokine production
|
650 |
|
4 |
|a Flow cytometry
|
650 |
|
4 |
|a T cell
|
650 |
|
7 |
|a Cytokines
|2 NLM
|
650 |
|
7 |
|a Tumor Necrosis Factor-alpha
|2 NLM
|
650 |
|
7 |
|a Interferon-gamma
|2 NLM
|
650 |
|
7 |
|a 82115-62-6
|2 NLM
|
700 |
1 |
|
|a Ticha, Olga
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Nechvatalova, Jana
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Kalina, Tomas
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Litzman, Jiri
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Mauri, Claudia
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Blair, Paul A
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 160(2015), 2 vom: 02. Okt., Seite 292-300
|w (DE-627)NLM098196855
|x 1521-7035
|7 nnns
|
773 |
1 |
8 |
|g volume:160
|g year:2015
|g number:2
|g day:02
|g month:10
|g pages:292-300
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1016/j.clim.2015.06.013
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_11
|
912 |
|
|
|a GBV_ILN_24
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 160
|j 2015
|e 2
|b 02
|c 10
|h 292-300
|